Table 2.
Main study endpoints in the two study treatment groups
| Frovatriptan | Rizatriptan | p | |
|---|---|---|---|
| Pain relief episodes at 2 h | 25 (58) | 27 (64) | NS |
| Pain free episodes at 2 h | 15 (31) | 20 (34) | NS |
| Pain relief episodes at 24 h | 35 (81) | 31 (74) | NS |
| Pain free episodes at 24 h | 33 (67) | 36 (61) | NS |
| Recurrent episodes at 24 h | 5 (10) | 19 (32) | <0.01 |
Data are reported as absolute (n) and relative (%) frequency. P refers to the statistical significance of the difference between the two study drugs